Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 102,459 | 0.2% | 226,000 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 91,492 | 0.2% | 233,612 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 111,750 | 0.2% | 251,011 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 120,579 | 0.2% | 248,709 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 99,889 | 0.2% | 248,049 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 121,653 | 0.2% | 261,575 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 124,933 | 0.2% | 266,540 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 96,372 | 0.2% | 305,875 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 117,001 | 0.2% | 287,550 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 104,116 | 0.2% | 299,409 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 103,742 | 0.2% | 294,796 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 96,372 | 0.2% | 305,875 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 89,180 | 0.2% | 308,815 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 90,069 | 0.2% | 311,075 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 88,898 | 0.2% | 315,475 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 82,047 | 0.2% | 314,393 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 71,230 | 0.1% | 324,362 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 59,274 | 0.1% | 326,776 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 67,473 | 0.1% | 334,640 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 71,766 | 0.1% | 333,966 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 82,515 | 0.2% | 349,136 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 96,552 | 0.2% | 354,815 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 102,911 | 0.3% | 354,488 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 82,358 | 0.3% | 346,113 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 73,567 | 0.2% | 336,000 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 34,605 | 0.1% | 365,496 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 25,540 | 0.1% | 361,140 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 29,155 | 0.1% | 392,400 | 12/31/2013 |